# OnCo record nct04496349 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04496349/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04496349", "NCT04496349" ;
  schema:name "A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL"@en ;
  schema:description "A phase 2 trial of APG-115 in hodgkin lymphoma, run by Ascentage Pharma Group Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04496349/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04496349> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2021-07-12" ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:companies <https://onco.cc/companies/ascentage-pharma/> .